HealthDay operates under the strictest editorial standards. Our syndicated news content is completely independent of any financial interests, is based solely on industry-respected sources and the latest scientific research, and is carefully fact-checked by a team of industry experts to ensure accuracy.
- All articles are edited and checked for factual accuracy by our Editorial Team prior to being published.
- Unless otherwise noted, all articles focusing on new research are based on studies published in peer-reviewed journals or issued from independent and respected medical associations, academic groups and governmental organizations.
- Each article includes a link or reference to the original source.
- Any known potential conflicts of interest associated with a study or source are made clear to the reader.
Please see our Editorial and Fact-Checking Policy for more detail.Editorial and Fact-Checking Policy
HealthDay Editorial Commitment
HeathDay is committed to maintaining the highest possible levels of impartial editorial standards in the content that we present on our website. All of our articles are chosen independent of any financial interests. Editors and writers make all efforts to clarify any financial ties behind the studies on which we report.
FRIDAY, June 3, 2022 (HealthDay News) -- The rate of adverse events within 90 days for patients undergoing total hip arthroplasty (THA) does not differ according to whether the surgeon performing the procedure is female or male, according to a study published online May 24 in the Journal of Bone and Joint Surgery.
Per Jolbäck, R.N., Ph.D., from the University of Gothenburg in Sweden, and colleagues conducted a retrospective study involving primary THAs performed for osteoarthritis between 2008 and 2016 at 10 hospitals in Western Sweden. Adverse events were retrieved from the regional patient register, and the impact of surgeon sex on adverse events was examined. Data were included for 11,993 primary THAs, performed by 200 surgeons (17.5 percent women).
The researchers found that the proportions of adverse events within 90 days were similar for female and male surgeons (6 and 7 percent, respectively). When all surgeons (both attendings and residents) were included in the analysis, no association was observed between surgeon sex and adverse events (adjusted odds ratio, 0.72; 95 percent confidence interval, 0.52 to 1.00). In a sensitivity analysis including only attendings, the results were similar (adjusted odds ratio, 0.88; 95 percent confidence interval, 0.60 to 1.29).
"We therefore conclude that there is no association between the rate of adverse events within 90 days postoperatively and the sex of the surgeon," the authors write.
One author disclosed financial ties to the medical device industry.
This story may be outdated. We suggest some alternatives.
The content contained in this article is over two years old. As such our recommendation is that you reference the articles below for the latest updates on this topic. This article has been left on our site as a matter of historic record. Please contact us at email@example.com with any questions.
Published on June 03, 2022